
Sign up to save your podcasts
Or


Motley Fool healthcare analysts take a closer look at Novartis’ pipeline, its most recent earnings report, and what lies ahead for 2015 and beyond.
By The Motley Fool4.5
825825 ratings
Motley Fool healthcare analysts take a closer look at Novartis’ pipeline, its most recent earnings report, and what lies ahead for 2015 and beyond.

3,220 Listeners

808 Listeners

946 Listeners

1,605 Listeners